By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.

Most days, preparing and prosecuting patent applications follows a familiar rhythm. Talk with the inventors. Draft the ...

The controversial "summoning a character" patent acquired by Nintendo has raised uproar, and here's why it was allowed to ...

Stellantis filed this patent in Germany, and the basic idea seems pretty simple. The car's computers keep track of a ...

A team of entomologists went into Yellowstone National Park to understand how a tiny beetle could thrive in an incredibly ...

Detailed price information for Bitmine Immersion Technologies Inc (BMNR-A) from The Globe and Mail including charting and ...

The design drawings of the bike closely resemble Wahoo’s Kickr Bike Pro, which was released this month with a new ‘grade simulation’ tool for climbing. This new product, however, has a larger, ...

AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical leader known for therapies across immunology, oncology, and neuroscience, ...

Olga Berson of Thompson Coburn LLP discusses opportunities as well as intellectual property pitfalls for sovereign wealth ...

The complex turbocharger setup includes a geared input shaft that has its own clutch and brake for greater flexibility.

Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application No.